Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 57 min ago
Peer-reviewedCC BYFrontiers in oncology

ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma

  1. 1Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University , ,
  2. 2Cancer Institute, Fourth Hospital of Hebei Medical University , ,

Related

  1. An explainable machine learning model combining intratumoral and peritumoral computed tomography radiomics with maximum standard uptake value for predicting International Association for the Study of Lung Cancer grading and prognosis in stage I pure-solid lung adenocarcinoma.
    Hanzhe Wang, Junping Lan, Yimin Chen +11
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  2. MRI-based intratumoral and peritumoral heterogeneity for predicting intracranial progression in EGFR-mutant lung adenocarcinoma patients with treatment-naive brain metastases receiving first-line third-generation EGFR-TKIs.
    Guangchuan Deng, Houying Li, Zhengjun Dai +5
    Journal of translational medicinePeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCPMC
  3. Metabolic signature of phosphoethanolamine and arginine pathways predicts prognosis and immunotherapy resistance in lung adenocarcinoma
    Tao Wang, Hongwei Li, Fei Ding
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Molecular biomarkers for diagnosis, prognosis, precision therapy, and immunotherapy in cholangiocarcinoma, cHCC-CCA, and HCC
    Jingguo Sun, Yingjie Lu, Lu Chang +4
    Hepatology communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Editorial: AI-powered insights: predicting treatment response and prognosis in breast cancer
    Tamer Ahmed Farrag, Ashraf Elbatanony, Mona Zaky +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
BibTeX
@article{liu2026atf4,
  title = {{ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma}},
  author = {Yanjie Liu and Dongli Guo and Daojuan Li and Jing Jin},
  journal = {Frontiers in oncology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655137},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma
AU  - Yanjie Liu
AU  - Dongli Guo
AU  - Daojuan Li
AU  - Jing Jin
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in oncology
UR  - https://europepmc.org/article/PMC/PMC13655137
SN  - 2234-943X
ER  -